Two different methods for donor hepatic transection: Cavitron ultrasonic surgical aspirator with bipolar cautery versus cavitron ultrasonic surgical aspirator with radiofrequency coagulator—A randomized controlled trial

Walid M. El Moghazy, Mohammed S. Hedaya, Toshimi Kaido, Hiroto Egawa, Shinji Uemoto, Yasutsugu Takada – 24 December 2008 – The aim of this study was to compare the Cavitron ultrasonic surgical aspirator (CUSA) with bipolar cautery (BP) to CUSA with a radiofrequency coagulator [TissueLink (TL)] in terms of efficacy and safety for hepatic transection in living donor liver transplantation. Twenty‐four living liver donors (n = 12 for each group) were randomized to undergo hepatic transection using CUSA with BP or CUSA with TL.

Abdominal drains in liver transplantation: Useful tool or useless dogma? A matched case‐control study

Olivier de Rougemont, Philipp Dutkowski, Markus Weber, Pierre‐Alain Clavien – 24 December 2008 – On the basis of the growing evidence from randomized trials that routine prophylactic drainage is unnecessary in liver surgery or even harmful in chronic liver disease, we challenged the concept of prophylactic drainage in orthotopic liver transplantation (OLT). Since September 2006, we omitted drains in every patient who underwent OLT, regardless of the procedure. Thirty‐five cadaveric OLTs were performed during a 12‐month period.

The validity of EQ‐5D US preference weights in liver transplant candidates and recipients

Robert T. Russell, Irene D. Feurer, Panarut Wisawatapnimit, C. Wright Pinson – 24 December 2008 – Health utility instruments assess patients' valuation of specific health states, which can be converted to quality‐adjusted life years for cost‐utility analysis. Data from the EQ‐5D, a generic health‐related quality of life questionnaire from EuroQoL, can be reported as 5 health status scores or as a single health preference weight (HPW). US population–based HPWs were published by Shaw and colleagues in 2005 (Med Care 2005;43:203‐220).

Pathobiology of biliary epithelia and cholangiocarcinoma: Proceedings of the Henry M. and Lillian Stratton basic research single‐topic conference

Alphonse E. Sirica, Michael H. Nathanson, Gregory J. Gores, Nicholas F. LaRusso – 24 November 2008 – In June 2008, the American Association for the Study of Liver Diseases (AASLD) sponsored the Henry M. and Lillian Stratton Basic Research Single‐Topic Conference on the Pathobiology of Biliary Epithelia and Cholangiocarcinoma, which was held in Atlanta, GA. Attendees from 12 different countries participated in this conference, making it a truly international scientific event.

Acute kidney injury in cirrhosis

Guadalupe Garcia‐Tsao, Chirag R. Parikh, Antonella Viola – 24 November 2008 – Acute renal failure (ARF), recently renamed acute kidney injury (AKI), is a relatively frequent problem, occurring in approximately 20% of hospitalized patients with cirrhosis. Although serum creatinine may underestimate the degree of renal dysfunction in cirrhosis, measures to diagnose and treat AKI should be made in patients in whom serum creatinine rises abruptly by 0.3 mg/dL or more (≥26.4 μmol/L) or increases by 150% or more (1.5‐fold) from baseline.

Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor α, reduced glutathione, and transforming growth factor β–dependent mechanisms

Francisco Javier Cubero, Natalia Nieto – 24 November 2008 – Because of the contribution of ethanol and polyunsaturated fatty acids (PUFAs) to alcoholic liver disease, we investigated whether chronic ethanol administration and arachidonic acid (AA) could synergistically mediate Kupffer cell (KC) activation and modulate the stellate cell (HSC) fibrogenic response.

Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end‐binding protein 1 in hepatocellular carcinoma

Tatsuya Orimo, Hidenori Ojima, Nobuyoshi Hiraoka, Shigeru Saito, Tomoo Kosuge, Tatsuhiko Kakisaka, Hideki Yokoo, Kazuaki Nakanishi, Toshiya Kamiyama, Satoru Todo, Setsuo Hirohashi, Tadashi Kondo – 24 November 2008 – Histological differentiation is a major pathological parameter associated with poor prognosis in patients with hepatocellular carcinoma (HCC) and the molecular signature underlying HCC differentiation may involve key proteins potentially affecting the malignant characters of HCC.

Subscribe to